Login / Signup

Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.

Yongfeng XuQunli XiongYang YangNingna WengJunjun LiJinlu LiuXiaojuan YangZhu ZengZhiwei ZhangQing Zhu
Published in: Journal of clinical medicine (2022)
Serum NRDC may play a useful diagnostic biomarker to evaluate the aggressive clinical features in PAAD patients.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis